FDA staff seek new warning on Baxter anesthetic
WASHINGTON (Reuters) - U.S. regulatory staff have recommended updating the prescribing instructions for a Baxter International anesthesia drug after three reports of cardiac arrest in children, documents released on Friday said.
<p>You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~a/reuters/healthNews?i=Qtqya0" border="0)
</img>
</p><div class="feedflare">
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=ZqwmCCF" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=6h8BNLf" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=orHOhrf" border="0)
</img>
</div>
![](http://feeds.reuters.com/~r/reuters/healthNews/~4/255883242" height="1" width="1)
You are not allowed to view links.
Register or
Login
